International real-world study of DLL3 expression in patients with small cell lung cancer


Rojo F., Corassa M., Mavroudis D., Oz A. B. , Biesma B., Brcic L., ...More

LUNG CANCER, vol.147, pp.237-243, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 147
  • Publication Date: 2020
  • Doi Number: 10.1016/j.lungcan.2020.07.026
  • Journal Name: LUNG CANCER
  • Journal Indexes: Science Citation Index Expanded, Scopus, Academic Search Premier, PASCAL, EMBASE, MEDLINE
  • Page Numbers: pp.237-243

Abstract

Objectives: Expression of the Notch-family ligand delta-like protein 3 (DLL3), a potential therapeutic target in small cell lung cancer (SCLC), has not been assessed in the real-world setting. To identify the real-world utility of DLL3 as an SCLC therapeutic target, we performed the largest retrospective international noninterventional study to date to evaluate DLL3 prevalence in SCLC patients.